BioSpace News Archive

Silk Road Medical, Inc., a company focused on reducing the risk of stroke and its devastating impact, announced the company will be participating in the upcoming Stifel 2020 Virtual Healthcare Conference.

Cytokinetics, Incorporated reported financial results for the third quarter of 2020.

Positive topline data from GALLOP Phase 2 clinical trial of imsidolimab in moderate to severe Generalized Pustular Psoriasis (GPP) announced in October 2020

Keros Therapeutics, Inc. announced that four abstracts will be presented from the KER-050 and ALK2 hematology programs, including topline data from Keros’ Phase 1 clinical trial of KER-047, at the 62nd American Society of Hematology Annual Meeting and Exposition, to be held as a virtual event from December 5-8, 2020.

TransMedics Group, Inc. (“TransMedics”) (Nasdaq: TMDX), a medical technology company that is transforming organ transplant therapy for patients with end-stage lung, heart and liver failure, today reported financial results for the quarter ended September 30, 2020.

Perrigo Company plc (NYSE; TASE: PRGO), a leading provider of Quality, Affordable Self-Care Products, today announced financial results for the third quarter ended September 26, 2020

Vapotherm, Inc. (NYSE: VAPO), (“Vapotherm” or the “Company”), a global medical technology company focused on the development and commercialization of its proprietary high velocity therapy, which is used to treat patients of all ages suffering from respiratory distress, today announced third quarter 2020 financial results.

Acceleron Pharma Inc. (Nasdaq: XLRN), a leading biopharmaceutical company in the discovery, development, and commercialization of TGF-beta superfamily therapeutics to treat serious and rare diseases, announced today that data from six clinical abstracts on REBLOZYL

Innovative EVO Viva Implantable Collamer® Lens Corrects Near, Intermediate and Distance Vision

STAAR Surgical Company, a leading developer, manufacturer and marketer of implantable lenses and companion delivery systems for the eye, reported financial results for the third quarter ended October 2, 2020.